199 related articles for article (PubMed ID: 11379777)
1. N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.
Kita T; Tanigawara Y; Chikazawa S; Hatanaka H; Sakaeda T; Komada F; Iwakawa S; Okumura K
Biol Pharm Bull; 2001 May; 24(5):544-9. PubMed ID: 11379777
[TBL] [Abstract][Full Text] [Related]
2. Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.
Salazar-González R; Gómez R; Romano-Moreno S; Medellín-Garibay S; Núñez-Ruíz A; Magaña-Aquino M; Milán-Segovia RC; Portales-Pérez DP
Mol Biol Rep; 2014 Dec; 41(12):7833-43. PubMed ID: 25163630
[TBL] [Abstract][Full Text] [Related]
3. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
5. Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients.
Igumnova V; Capligina V; Krams A; Cirule A; Elferts D; Pole I; Jansone I; Bandere D; Ranka R
J Infect Chemother; 2016 Jul; 22(7):472-7. PubMed ID: 27236516
[TBL] [Abstract][Full Text] [Related]
6. [Cytochrome P450 and NAT2 polymorphisms and drug metabolism in DOTS].
Castillejos-López Mde J; García-Sancho MC; Quiñones-Falconi F; Pérez-Padilla JR
Rev Invest Clin; 2008; 60(1):47-57. PubMed ID: 18589587
[TBL] [Abstract][Full Text] [Related]
7. The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients.
Chen B; Li JH; Xu YM; Wang J; Cao XM
Clin Chim Acta; 2006 Mar; 365(1-2):104-8. PubMed ID: 16182272
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients.
Fukino K; Sasaki Y; Hirai S; Nakamura T; Hashimoto M; Yamagishi F; Ueno K
J Toxicol Sci; 2008 May; 33(2):187-95. PubMed ID: 18544910
[TBL] [Abstract][Full Text] [Related]
9. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
Donald PR; Parkin DP; Seifart HI; Schaaf HS; van Helden PD; Werely CJ; Sirgel FA; Venter A; Maritz JS
Eur J Clin Pharmacol; 2007 Jul; 63(7):633-9. PubMed ID: 17505821
[TBL] [Abstract][Full Text] [Related]
10. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
[TBL] [Abstract][Full Text] [Related]
11. Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.
Ohno M; Yamaguchi I; Yamamoto I; Fukuda T; Yokota S; Maekura R; Ito M; Yamamoto Y; Ogura T; Maeda K; Komuta K; Igarashi T; Azuma J
Int J Tuberc Lung Dis; 2000 Mar; 4(3):256-61. PubMed ID: 10751073
[TBL] [Abstract][Full Text] [Related]
12. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
[TBL] [Abstract][Full Text] [Related]
13. Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2.
Kubota R; Ohno M; Hasunuma T; Iijima H; Azuma J
Eur J Clin Pharmacol; 2007 Oct; 63(10):927-33. PubMed ID: 17665185
[TBL] [Abstract][Full Text] [Related]
14. Gene dose effect of NAT2 variants on the pharmacokinetics of isoniazid and acetylisoniazid in healthy Chinese subjects.
Bing C; Xiaomeia C; Jinhenga L
Drug Metabol Drug Interact; 2011; 26(3):113-8. PubMed ID: 21980963
[TBL] [Abstract][Full Text] [Related]
15.
Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
[TBL] [Abstract][Full Text] [Related]
16. Age-distribution and genotype-phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment.
Keller GA; Fabian L; Gomez M; Gonzalez CD; Diez RA; Di Girolamo G
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):292-302. PubMed ID: 24447650
[TBL] [Abstract][Full Text] [Related]
17. Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.
Singh N; Dubey S; Chinnaraj S; Golani A; Maitra A
Mol Diagn Ther; 2009; 13(1):49-58. PubMed ID: 19351215
[TBL] [Abstract][Full Text] [Related]
18. PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.
Balhara A; Singh S
Pharm Res; 2021 Sep; 38(9):1485-1496. PubMed ID: 34518943
[TBL] [Abstract][Full Text] [Related]
19. A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy.
Hashiguchi M; Ohno K; Sakuma A; Hino F; Tanaka T; Ohtsuji M; Matsumoto N; Yanase K; Urae A; Hosogai Y; Sato N; Yazaki A; Matsuda K; Yamazaki K; Rikihisa T
J Clin Pharmacol; 2002 Feb; 42(2):151-6. PubMed ID: 11831537
[TBL] [Abstract][Full Text] [Related]
20. Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Hein DW; Doll MA
Arch Toxicol; 2017 Aug; 91(8):2827-2835. PubMed ID: 28523442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
